过去一年中添加的文章，按日期排序
[引用][C] Preclinical Characterization of the Omicron XBB. 1.5-Adapted BNT162b2 COVID-19 Vaccine (preprint)
[PDF][PDF] Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants
D Planas, L Peng, L Zheng, F Guivel-Benhassine… - Heliyon, 2024 - cell.com
247 天前 - … SARS-CoV-2 121 strains were incubated with sera at the … and 163 VQU, Duke
Human Vaccine Institute. Cell-based … with two doses of mRNA BNT162b2 were randomly 210 …
Human Vaccine Institute. Cell-based … with two doses of mRNA BNT162b2 were randomly 210 …
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID …
I Varasi, A Lai, L Fiaschi, A Bergna, A Gatti… - Journal of …, 2023 - journalofinfection.com
356 天前 - … and vaccine induced immunity elicited by pre-omicron … of the monovalent BNT162b2
COVID-19 mRNA vaccine. Plasma … variants on the neutralization by sera of patients treated …
COVID-19 mRNA vaccine. Plasma … variants on the neutralization by sera of patients treated …